NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome-Reference-Cited by-同舟云学术

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

Published:2017-05 Issue:5 Volume:66 Page:910-918
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Zeuzem Stefan,Mizokami Masashi,Pianko Stephen,Mangia Alessandra,Han Kwang-Hyub,Martin Ross,Svarovskaia Evguenia,Dvory-Sobol Hadas,Doehle Brian,Hedskog Charlotte,Yun Chohee,Brainard Diana M.,Knox Steven,McHutchison John G.,Miller Michael D.,Mo Hongmei,Chuang Wan-Long,Jacobson Ira,Dore Gregory J.,Sulkowski Mark

Publisher

Elsevier BV

Subject

Hepatology

Reference27 articles.

1. Rapid emergence of protease inhibitor resistance in hepatitis C virus;Rong;Sci Transl Med,2010

2. Baseline and post-baseline resistance analyses of phase 2/3 studies of ledipasvir/sofosbuvir±RBV;Sarrazin;Hepatology,2014

3. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment;Bartels;J Virol,2013

4. Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b;Suzuki;J Clin Virol,2012

5. Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir;Krishnan;Antimicrob Agents Chemother,2015

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China;Infection, Genetics and Evolution;2024-09

2. Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease;Viruses;2024-08-03

3. Identifying Gaps in the Treatment Guidelines for Hepatitis C in Peru to Meet International Standards: A Narrative Review;Journal of Clinical Medicine;2024-06-30

4. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review;Microorganisms;2024-05-21

5. Molecular characterization of the nonstructural 5A (NS5A) region of hepatitis C virus in Thai blood donors;Archives of Microbiology;2024-04-15